Preview

Koloproktologia

Advanced search

THE FIRST EXPERIENCE OF CONTRAST-ENHANCED ULTRASOUND IN EPITHELIAL RECTAL TUMORS

https://doi.org/10.33878/2073-7556-2020-19-4-57-70

Abstract

AIM: to evaluate the diagnostic capabilities of contrast-enhanced ultrasound for the diagnostics of epithelial rectal tumors.

PATIENTS AND METHODS: the study included 15 patients, who underwent endorectal ultrasound and transvaginal contrast-enhanced ultrasound. All the patients underwent surgery.

RESULTS: morphology revealed adenomas in 9 cases, and adenocarcinomas with different invasion depth in 6 cases. When analyzing the tumors contrast, significant differences in arrival time of contrasting between adenomas and adenocarcinomas were obtained (p = 0.041), and the contrast enhancement of adenocarcinomas was faster (p = 0.036). Negative correlations of peak intensity of contrast enhancement of hypoenhanced zones in adenocarcinoma with indices T (rxy =-0.781; p = 0.001) and N (rxy = - 0.519; p = 0.047)and a positive correlation with the tumor differentiation degree (rxy=0.742; p = 0.002) were established. Also, the negative correlation of the arrival time with the index T (rxy=-0.552; p=0.033) was found.

CONCLUSION: contrast-enhanced ultrasound is an imaging technique that allows real-time qualitative and quantitative assessment of tumor tissue perfusion. The method is not standardized, but it can be a useful non-invasive method for assessing the blood supply of rectal tumors at the preoperative stage, and also has the potential to assess risk factors for lymphogenic metastasis.

About the Authors

E. M. Bogdanova
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia


L. P. Orlova
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia


Yu. L. Trubacheva
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia


E. A. Khomyakov
Ryzhikh National Medical Research Center of Coloproctology
Salyama Adilya str., 2, Moscow, 123423, Russia


E. G. Rybakov
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Salyama Adilya str., 2, Moscow, 123423, Russia



References

1. Vasiliev A.Yu., Kapustin V.V., Vasilieva Yu.N., Shumina Ya.A. Comparison of Ultrasound Contrast Agents (Literature Review). Ultrasound and Functional Diagnostics. 2016; №4, pp.73-81. (In Russ.).

2. Sencha A.N., Mogutov M.S., Patrunov Yu.N. et al. Ultrasound examination using contrast agents. Moscow: Vidar-M, 2015. 144 p. (In Russ.).

3. Askerova N., Stepanova Y., Timina I. Quantitative perfusion analysis and time intensity curve analysis in differential diagnosis of solid pancreatic tumors by contrast-enhanced ultrasound. A pilot study. Medical Vizualization. 2017; v.21, №3, pp. 82-87. (In Russ.).

4. Bikeev Yu.V., Sencha A.N., Rodionov V.V. et al. Qualitative analysis of ultrasound using a contrast agent in the differential diagnosis of palpable breast abnormalities. Medical Vizualization. 2019, 1: 87–96. (In Russ.).

5. Vetsheva N.N., Fisenko E.P., Stepanova Yu.A., KamalovYu.R., et al. Contrast Enhanced Ultrasound: Terminology, Technical and Methodological Aspects. Medical Vizualization. 2016;№4:132-140.

6. Askerova N.N., Karmazanovsky G.G. Contrast-Enhanced Imaging with Utilization of SonoVue®: Ways of Improvement of Ultrasonic Diagnosis of Focal Lesions in Parenchymal Organs of Abdominal Cavity and Retroperitoneal. Medical Vizualization. 2015; №1 pp.115-125. (In Russ.).

7. DeLeon A, Perera R, Hernandez C, et al. Contrast Enhanced Ultrasound Imaging by Nature-Inspired Ultrastable Echogenic Nanobubble. Nanoscale, 2019; DOI: 10.1039/C9NR04828F.

8. Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med, 2012;33:344-51.

9. Peronneau P, Lassau N, Leguerney I, et al. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization. Ultraschall Med, 2010;31:370-378. DOI: 10.1055/s-0029-1245450 .

10. Averkiou M, Lampaskis M, Kyriakopoulou K, et al. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol, 2010; 36:68-77. DOI: 10.1016/j.ultrasmedbio.2009.07.005 .

11. Williams R, Hudson JM, Lloyd BA, et al. Dynamic Microbubble Contrast enhanced US to Measure Tumor Response to Targeted Therapy: A Proposed Clinical Protocol with Results from Renal Cell Carcinoma Patients Receiving Antiangiogenic Therapy. Radiology. 2011;260:581-590. DOI: 10.1148/radiol.11101893 .

12. Lu M, Yan B, Song J, et al. Double-Contrast-Enhanced Sonography for Diagnosis of Rectal Lesions With Pathologic Correlation. Journal of Ultrasoundin Medicine, 2014;33(4):575-583. DOI: 10.7863/ultra.33.4.575 .

13. Wang Y, Li L, Wang YXJ, et al. Time-Intensity Curve Parameters in Rectal Cancer Measured Using Endorectal Ultrasonography with Sterile Coupling Gels Filling the Rectum: Correlations with Tumor Angiogenesis and Clinicopathological Features. Bio Med ResInt. 2014; 2014:587806. DOI:10.1155/2014/587806.

14. Cârțână ET, Gheonea DI, Cherciu IF, et al. Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis. Endosc Ultrasound. 2018;7:175-83. DOI: 10.4103/eus.eus_7_17.


Review

For citations:


Bogdanova E.M., Orlova L.P., Trubacheva Yu.L., Khomyakov E.A., Rybakov E.G. THE FIRST EXPERIENCE OF CONTRAST-ENHANCED ULTRASOUND IN EPITHELIAL RECTAL TUMORS. Koloproktologia. 2020;19(4):57-70. https://doi.org/10.33878/2073-7556-2020-19-4-57-70

Views: 477


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)